Reshkin S J, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, Alunni-Fabbroni M, Casavola V, Tommasino M
Department of General and Environmental Physiology, University of Bari, Bari, Italy.
FASEB J. 2000 Nov;14(14):2185-97. doi: 10.1096/fj.00-0029com.
In this study we investigate the mechanism of intracellular pH change and its role in malignant transformation using the E7 oncogene of human papillomavirus type 16 (HPV16). Infecting NIH3T3 cells with recombinant retroviruses expressing the HPV16 E7 or a transformation deficient mutant we show that alkalinization is transformation specific. In NIH3T3 cells in which transformation can be turned on and followed by induction of the HPV16 E7 oncogene expression, we demonstrate that cytoplasmic alkalinization is an early event and was driven by stimulation of Na+/H+ exchanger activity via an increase in the affinity of the intracellular NHE-1 proton regulatory site. Annulment of the E7-induced cytoplasmic alkalinization by specific inhibition of the NHE-1, acidification of culture medium, or clamping the pHi to nontransformed levels prevented the development of later transformed phenotypes such as increased growth rate, serum-independent growth, anchorage-independent growth, and glycolytic metabolism. These findings were verified in human keratinocytes (HPKIA), the natural host of HPV. Results from both NIH3T3 and HPKIA cells show that alkalinization acts on pathways that are independent of the E2F-mediated transcriptional activation of cell cycle regulator genes. Moreover, we show that the transformation-dependent increase in proliferation is independent of the concomitant stimulation of glycolysis. Finally, treatment of nude mice with the specific inhibitor of NHE-1, DMA, delayed the development of HPV16-keratinocyte tumors. Our data confirm that activation of the NHE-1 and resulting cellular alkalinization is a key mechanism in oncogenic transformation and is necessary for the development and maintenance of the transformed phenotype.
在本研究中,我们利用人乳头瘤病毒16型(HPV16)的E7癌基因,研究细胞内pH变化的机制及其在恶性转化中的作用。用表达HPV16 E7或转化缺陷突变体的重组逆转录病毒感染NIH3T3细胞,我们发现碱化是转化特异性的。在可通过诱导HPV16 E7癌基因表达开启转化的NIH3T3细胞中,我们证明细胞质碱化是一个早期事件,是由细胞内NHE-1质子调节位点亲和力增加刺激Na+/H+交换器活性驱动的。通过特异性抑制NHE-1、酸化培养基或将细胞内pH钳制在未转化水平来消除E7诱导的细胞质碱化,可阻止后期转化表型的发展,如生长速率增加、血清非依赖性生长、锚定非依赖性生长和糖酵解代谢。这些发现已在HPV的天然宿主人角质形成细胞(HPKIA)中得到验证。NIH3T3和HPKIA细胞的结果均表明,碱化作用于独立于细胞周期调节基因的E2F介导的转录激活的途径。此外,我们表明转化依赖性增殖增加与糖酵解的伴随刺激无关。最后,用NHE-1特异性抑制剂DMA处理裸鼠,可延缓HPV16角质形成细胞瘤的发展。我们的数据证实,NHE-1的激活和由此导致的细胞碱化是致癌转化的关键机制,是转化表型发展和维持所必需的。